France · Source-listed medicine information

France / CIS 62553246

ULTIBRO BREEZHALER 85 microgrammes/43 microgrammes, poudre pour inhalation en gélule

poudre pour inhalation en gélule · inhalée

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formpoudre pour inhalation en gélule
Routeinhalée
Ingredient entries4
CountryFrance

Product identity

At a glance

Authorisation holder
NOVARTIS EUROPHARM (IRLANDE)
Authorisation status
Autorisation active
Market status
Commercialisée
Country
France
Source reference
CIS 62553246

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for ULTIBRO BREEZHALER 85 microgrammes/43 microgrammes, poudre pour inhalation en gélule
IngredientStrength / referenceSource role
BROMURE DE GLYCOPYRRONIUMpoudre63 microgrammesune géluleSAGroup 2
GLYCOPYRRONIUMpoudre50 microgrammesune géluleFTGroup 2
MALÉATE D'INDACATÉROLpoudre143 microgrammesune géluleSAGroup 1
INDACATÉROLpoudre110 microgrammesune géluleFTGroup 1

Pack references

Presentations (2)

30 plaquette(s) polyamide aluminium PVC-Aluminium de 1 gélule(s) avec inhalateur(s) acrylonitrile butadiène styrène

CIP13 3400927566479

Présentation active · Déclaration de commercialisation
10 plaquette(s) polyamide aluminium PVC-Aluminium de 1 gélule(s) avec inhalateur(s) acrylonitrile butadiène styrène

CIP13 3400930038802

Présentation active · Déclaration d'arrêt de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 62553246 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source fileRetrievedSource file modified
fr_products.txtNot supplied
fr_composition.txtNot supplied
fr_packs.txtNot supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →